Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment-MedSci.cn

Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment

Pedrazzoli, ABA; Moreno, V; Gomez-Roca, CA; Even, C; Cassier, P; Guerrero, TCH; de Miguel, M; Korakis, I; Purcea, D; Roy, E; Gollmer, K; Riff, C; Szyldergemajn, SA; Calvo, E

ANNALS OF ONCOLOGY, 2020; 31 (): S483

科室
- - 订阅+
  - 更多科室
工具
服务